Delivery Order SPE2DR25D2205-SPE2DR26F1S75
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,630.77 to AmerisourceBergen Drug Corp for Albuterol HFA 90MCG inhalers. This is a firm fixed price delivery order under a non-set-aside competitive procurement, with a completion deadline of December 31, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will serve as the place of performance for this order. The contract represents a continuation of the company's significant role as a...
- The Defense Logistics Agency awarded a $1,562.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of December 12, 2025. This non-set-aside delivery order represents a single pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,177.63 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhaler 8.5 gm, with an ultimate completion date of September 11, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader supply relationship with the federal government for...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.06 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Albuterol HFA 90 MCG inhalers (8.5GM) under a firm fixed price contract valued at $1,442.88. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,445.76 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,863.66 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of July 31, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Albuterol HFA 90 MCG Inhalers (8.5 GM) with a ceiling value of $1,373.40. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to complete by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.36 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhalers (8.5 grams) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1S75Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,224.36 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of January 6, 2026. This non-set-aside contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen regularly fulfills competitively awarded delivery orders across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating its capability to meet diverse federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/4/26 |